# CompariSon Between the EuroPeAn and Japanese pathologiCal InvEstigation for Colon Cancer (SPACE)

Source: https://onco.cc/trials/nct06119867/  
OnCo record `nct06119867` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 3 trial in colorectal cancer, run by Russian Society of Colorectal Surgeons, now recruiting.

## Summary

CompariSon Between the EuroPeAn and Japanese pathologiCal InvEstigation for Colon Cancer (SPACE) is a phase 3, randomised interventional study registered as NCT06119867 by Russian Society of Colorectal Surgeons, with a registry enrolment figure of 430 participants, started 2023-11-14 and due to reach its primary completion in 2027-04-12. Interventions recorded: Japanese pathological investigation; European pathological investigation. Conditions listed: Colonic Neoplasms. Primary outcome: Comparision of the incidence of stage III colon cancer between European and Japanese pathological investigation methods.. Colorectal eligibility wording from the registry: "* Patients diagnosed with colon cancer who underwent colectomy;". Sites: Russia. No results are recorded here; the registry entry is the source.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-09-24
- Also known as: SPACE
- Tags: ctgov-ingest; colorectal-deep-dive
- Registry id: NCT06119867
- Phase: 3
- Setting: Comparison Between the European and Japanese Pathological Investigation for Colon Cancer (SPACE)
- Sponsor: Russian Society of Colorectal Surgeons
- Enrolled: 430

## Sources

- ClinicalTrials.gov NCT06119867: https://clinicaltrials.gov/study/NCT06119867

## Connected records

- cancers: [Colon cancer (adenocarcinoma of the colon)](https://onco.cc/cancers/colon-cancer/)
- terms: [Colorectal cancer trials open today (registry snapshot)](https://onco.cc/terms/colorectal-trials-open-today/)

---
JSON: https://onco.cc/api/v1/entities/nct06119867.json